Capitalising on its significant experience in the Federal Patent Court and the Federal Supreme Court, Bär & Karrer Ltd. is able to represent Novartis, Sandoz and a variety of other clients in high-stakes mandates. Operating across technology, life sciences and consumer goods industries among others, the experienced team is routinely entrusted with significant transactional work as well as specialised IP transactions. The practice is led by Markus Wang, who is especially noted for his extensive capabilities across a range of contentious and non-contentious work, and he is particularly active in the pharma, biotech and IT sector.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘They can identify very well with our company and know all the processes and procedures. For this reason, we see great added value for our business in Switzerland and cooperation in the international environment.’

  • ‘The Team of Markus Wang and Markus Wang himself stand out by managing to combine expert IP knowledge with the understanding of the dynamics of M&A transactions.’

  • ‘Markus Wang delivered highest quality advice and displayed spot-on contract drafting skills on a very fast paced and highly complex major M&A transactions.’

  • 'Exceptional team of transactional attorneys and IP litigators. Very responsive, client- and goal-orientated. No unnecessary legaleasing, but tailor-made business advice.’
  • ‘Markus Wang is clearly the most brilliant thinker and smartest IP attorney in Switzerland. He has a quiet personality and thus does not like to boast his qualities. But everyone who worked with him or against him in litigation matters or contract negotiations must agree that Markus Wang is probably the toughest guy one can have on the other side of the table -- always a step ahead with his brilliant thinking!'

  • ‘Very experienced and great to work with. Key strengths are complex legal matters in intellectual property.’

  • ‘Markus Wang is extremely experienced, very responsive and great to work with.’

Key clients

  • Novartis
  • Sandoz
  • Medbase
  • UNIVERSAL GENEVE SA
  • RQM
  • X-Technology Swiss research & development AG / X-Technology Swiss GmbH
  • CVC
  • SK Spice Sarl and Archroma IP GmbH
  • ELCA Group SA
  • Viseca Payment Services
  • EnerSys

Work highlights

  • Represented traditional Swiss watchmaker Universal Geneve in trademark nullity proceedings brought by Beau HLB for alleged non-use at the Federal Supreme Court with a successful result for the client.
  • Represented SK Spice Sarl and Archroma IP GmbH in proceedings against Clariant at and the Swiss Federal Supreme Court in a case relating to the grant of commercial patent and know-how licenses, with a successful result for the client.
  • Representing Swiss payment service providers and Swiss banks against technology company in a dispute concerning alleged patent infringement.

Practice head

The lawyer(s) leading their teams.

Markus Wang